Works by Murakami, Eriko


Results: 8
    1

    Immune‐Related Adverse Events by Immune Checkpoint Inhibitors Significantly Predict Durable Efficacy Even in Responders with Advanced Non‐Small Cell Lung Cancer.

    Published in:
    Oncologist, 2020, v. 25, n. 4, p. e679, doi. 10.1634/theoncologist.2019-0299
    By:
    • Akamatsu, Hiroaki;
    • Murakami, Eriko;
    • Oyanagi, Jun;
    • Shibaki, Ryota;
    • Kaki, Takahiro;
    • Takase, Eri;
    • Tanaka, Masanori;
    • Harutani, Yuhei;
    • Yamagata, Nao;
    • Okuda, Yuka;
    • Furuta, Katsuyuki;
    • Sugimoto, Takeya;
    • Teraoka, Shunsuke;
    • Hayata, Atsushi;
    • Tokudome, Nahomi;
    • Ozawa, Yuichi;
    • Mori, Keita;
    • Koh, Yasuhiro;
    • Yamamoto, Nobuyuki
    Publication type:
    Article
    2

    CD24, not CD47, negatively impacts upon response to PD‐1/L1 inhibitors in non–small‐cell lung cancer with PD‐L1 tumor proportion score < 50.

    Published in:
    Cancer Science, 2021, v. 112, n. 1, p. 72, doi. 10.1111/cas.14705
    By:
    • Ozawa, Yuichi;
    • Harutani, Yuhei;
    • Oyanagi, Jun;
    • Akamatsu, Hiroaki;
    • Murakami, Eriko;
    • Shibaki, Ryota;
    • Hayata, Atsushi;
    • Sugimoto, Takeya;
    • Tanaka, Masanori;
    • Takakura, Toshiaki;
    • Furuta, Katsuyuki;
    • Okuda, Yuka;
    • Sato, Kouichi;
    • Teraoka, Shunsuke;
    • Ueda, Hiroki;
    • Tokudome, Nahomi;
    • Kitamura, Yuka;
    • Fukuoka, Junya;
    • Nakanishi, Masanori;
    • Koh, Yasuhiro
    Publication type:
    Article
    3
    4
    5

    Pre-treatment serum protein levels predict survival of non-small cell lung cancer patients without durable clinical benefit by PD-1/L1 inhibitors.

    Published in:
    Cancer Immunology, Immunotherapy, 2022, v. 71, n. 9, p. 2109, doi. 10.1007/s00262-022-03141-4
    By:
    • Harutani, Yuhei;
    • Ozawa, Yuichi;
    • Murakami, Eriko;
    • Sato, Koichi;
    • Oyanagi, Jun;
    • Akamatsu, Hiroaki;
    • Yoshikawa, Takanori;
    • Shibaki, Ryota;
    • Sugimoto, Takeya;
    • Furuta, Katsuyuki;
    • Teraoka, Shunsuke;
    • Tokudome, Nahomi;
    • Hayata, Atsushi;
    • Ueda, Hiroki;
    • Nakanishi, Masanori;
    • Koh, Yasuhiro;
    • Yamamoto, Nobuyuki
    Publication type:
    Article
    6

    Mannitol versus furosemide in patients with thoracic malignancies who received cisplatin‐based chemotherapy using short hydration: A randomized phase II trial.

    Published in:
    Cancer Medicine, 2024, v. 13, n. 4, p. 1, doi. 10.1002/cam4.6839
    By:
    • Murakami, Eriko;
    • Akamatsu, Hiroaki;
    • Teraoka, Shunsuke;
    • Takakura, Toshiaki;
    • Takase, Eri;
    • Tanaka, Masanori;
    • Kaki, Takahiro;
    • Harutani, Yuhei;
    • Furuta, Katsuyuki;
    • Sugimoto, Takeya;
    • Shibaki, Ryota;
    • Fujimoto, Daichi;
    • Hayata, Atsushi;
    • Ozawa, Yuichi;
    • Nakanishi, Masanori;
    • Koh, Yasuhiro;
    • Shimokawa, Toshio;
    • Yamamoto, Nobuyuki
    Publication type:
    Article
    7
    8